Biofilm formation by pathogenic bacteria is a hallmark of chronic infections. In many cases, lectins play key roles in establishing biofilms. The pathogen Pseudomonas aeruginosa often exhibiting various drug resistances employs its lectins LecA and LecB as virulence factors and biofilm building blocks. Therefore, inhibition of the function of these proteins is thought to have potential in developing "pathoblockers" preventing biofilm formation and virulence. A covalent lectin inhibitor specific to a carbohydrate binding site is described for the first time. Its application in the LecA-specific in vitro imaging of biofilms formed by P. aeruginosa is also reported
A potent divalent ligand of the Pseudomonas aeruginosa adhesion lectin LecA was elaborated into a te...
A potent divalent ligand of the Pseudomonas aeruginosa adhesion lectin LecA was elaborated into a te...
The opportunistic bacterium Pseudomonas aeruginosa, often exhibiting multiresistance against convent...
International audienceBiofilm formation by pathogenic bacteria is a hallmark of chronic infections. ...
International audienceBiofilm formation by pathogenic bacteria is a hallmark of chronic infections. ...
International audiencePseudomonas aeruginosa is an opportunistic ESKAPE pathogen that produces two l...
Summary The work described in this thesis focuses on the development of inhibitors for Pseudomonas a...
Summary The work described in this thesis focuses on the development of inhibitors for Pseudomonas a...
International audienceThe opportunistic Gram-negative bacterium Pseudomonas aeruginosa is a leading ...
SummaryThe human pathogenic bacterium Pseudomonas aeruginosa produces a fucose-specific lectin, LecB...
The spread of antibiotic resistant bacteria is one of the most pressing problems in human health tod...
Copyright © 2015 Park-media, Ltd. This is an open access article distributed under the Creative Comm...
Pseudomonas aeruginosa is an opportunistic ESKAPE pathogen that produces two lectins, LecA and LecB,...
Pseudomonas aeruginosa is an opportunistic ESKAPE pathogen that produces two lectins, LecA and LecB,...
A potent divalent ligand of the Pseudomonas aeruginosa adhesion lectin LecA was elaborated into a te...
A potent divalent ligand of the Pseudomonas aeruginosa adhesion lectin LecA was elaborated into a te...
A potent divalent ligand of the Pseudomonas aeruginosa adhesion lectin LecA was elaborated into a te...
The opportunistic bacterium Pseudomonas aeruginosa, often exhibiting multiresistance against convent...
International audienceBiofilm formation by pathogenic bacteria is a hallmark of chronic infections. ...
International audienceBiofilm formation by pathogenic bacteria is a hallmark of chronic infections. ...
International audiencePseudomonas aeruginosa is an opportunistic ESKAPE pathogen that produces two l...
Summary The work described in this thesis focuses on the development of inhibitors for Pseudomonas a...
Summary The work described in this thesis focuses on the development of inhibitors for Pseudomonas a...
International audienceThe opportunistic Gram-negative bacterium Pseudomonas aeruginosa is a leading ...
SummaryThe human pathogenic bacterium Pseudomonas aeruginosa produces a fucose-specific lectin, LecB...
The spread of antibiotic resistant bacteria is one of the most pressing problems in human health tod...
Copyright © 2015 Park-media, Ltd. This is an open access article distributed under the Creative Comm...
Pseudomonas aeruginosa is an opportunistic ESKAPE pathogen that produces two lectins, LecA and LecB,...
Pseudomonas aeruginosa is an opportunistic ESKAPE pathogen that produces two lectins, LecA and LecB,...
A potent divalent ligand of the Pseudomonas aeruginosa adhesion lectin LecA was elaborated into a te...
A potent divalent ligand of the Pseudomonas aeruginosa adhesion lectin LecA was elaborated into a te...
A potent divalent ligand of the Pseudomonas aeruginosa adhesion lectin LecA was elaborated into a te...
The opportunistic bacterium Pseudomonas aeruginosa, often exhibiting multiresistance against convent...